{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:29:03Z","timestamp":1765268943398,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11605-023-05796-5","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T11:02:32Z","timestamp":1692010952000},"page":"2464-2473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"Alicia C.","family":"Smart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Niemierko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth K","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lillemoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence S.","family":"Blaszkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill N.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Weekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Warshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Fernandez-del","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-7959","authenticated-orcid":false,"given":"Florence K.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-023-05796-5_bb0010","unstructured":"Cancer Stat Facts: Pancreatic Cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program."},{"key":"10.1007\/s11605-023-05796-5_bb0015","doi-asserted-by":"crossref","unstructured":"Gillen S, Schuster T, B\u00fcschenfelde CM, Friess H, Kleeff J. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 2010 7 (4). Aug 2022 https:\/\/pubmed.ncbi.nlm.nih.gov\/20422030\/","DOI":"10.1371\/journal.pmed.1000267"},{"issue":"5","key":"10.1007\/s11605-023-05796-5_bb0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1245\/s10434-011-2110-8","article-title":"Neoadjuvant\/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies","volume":"19","author":"Andriulli","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-023-05796-5_bb0025","unstructured":"Conroy T, Castan F, Lopez A, et al. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial. JAMA Oncol 2022 2022 Sep, https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2795978"},{"issue":"8","key":"10.1007\/s11605-023-05796-5_bb0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jnci\/djz073","article-title":"Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis","volume":"111","author":"Janssen","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1007\/s11605-023-05796-5_bb0035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1007\/s11605-023-05796-5_bb0040","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1007\/s11605-023-05796-5_bb0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1007\/s11605-023-05796-5_bb0050","unstructured":"Katz MHG, Shi Q, Meyers J, et al. Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. JAMA Oncol 2022 Sep 2022, https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2794338"},{"key":"10.1007\/s11605-023-05796-5_bb0055","doi-asserted-by":"crossref","unstructured":"Janssen QP, van Dam JL, Bonsing BA, et al. Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial. BMC Cancer 2021 21 (1). Sep 2022, https:\/\/pubmed.ncbi.nlm.nih.gov\/33757440\/","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS4171"},{"issue":"4","key":"10.1007\/s11605-023-05796-5_bb0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","article-title":"Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation","volume":"94","author":"Krishnan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1007\/s11605-023-05796-5_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/COC.0000000000000472","article-title":"Dose escalation in stereotactic body radiation therapy for pancreatic cancer","volume":"42","author":"Zaorsky","year":"2019","journal-title":"American Journal of Clinical Oncology: Cancer Clinical Trials"},{"key":"10.1007\/s11605-023-05796-5_bb0070","doi-asserted-by":"crossref","unstructured":"Rossi G, Simoni N, Paiella S, et al. Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer. Front Oncol 2021;11.","DOI":"10.3389\/fonc.2021.662205"},{"key":"10.1007\/s11605-023-05796-5_bb0075","first-page":"21","article-title":"Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer","volume":"16","author":"Bertholet","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"4","key":"10.1007\/s11605-023-05796-5_bb0080","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2021.02.008","article-title":"Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer","volume":"110","author":"Courtney","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1007\/s11605-023-05796-5_bb0085","doi-asserted-by":"crossref","unstructured":"Reyngold M, Parikh P, Crane CH. Ablative radiation therapy for locally advanced pancreatic cancer: Techniques and results. Radiation Oncology. 2019;14(1).","DOI":"10.1186\/s13014-019-1309-x"},{"issue":"11","key":"10.1007\/s11605-023-05796-5_bb0090","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3390\/cancers14112688","article-title":"Stereotactic Ablative Radiotherapy Using CALYPSO\u00ae Extracranial Tracking for Intrafractional Tumor Motion Management\u2014A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study","volume":"14","author":"Kau\u010di\u0107","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1007\/s11605-023-05796-5_bb0095","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1245\/s10434-019-08084-2","article-title":"Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR\/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes","volume":"27","author":"Harrison","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-023-05796-5_bb0100","doi-asserted-by":"crossref","unstructured":"Jin L, Shi N, Ruan S, et al. The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis. Radiat Oncol 2020;15 (1). Sep 2022, https:\/\/pubmed.ncbi.nlm.nih.gov\/32272945\/","DOI":"10.1186\/s13014-020-01511-9"},{"issue":"6","key":"10.1007\/s11605-023-05796-5_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/COC.0000000000000336","article-title":"Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma","volume":"41","author":"Keane","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1007\/s11605-023-05796-5_bb0110","unstructured":"Parikh PJ. Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer - Full Text View - ClinicalTrials.gov [Internet]. 2018 Aug 30 2022, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03621644"},{"issue":"5","key":"10.1007\/s11605-023-05796-5_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijrobp.2022.09.010","article-title":"Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial","volume":"114","author":"Parikh","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1007\/s11605-023-05796-5_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11605-013-2375-2","article-title":"Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survival","volume":"18","author":"Gawlas","year":"2014","journal-title":"J Gastrointest Surg [Internet]"},{"issue":"10","key":"10.1007\/s11605-023-05796-5_bb0125","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s11605-012-1958-7","article-title":"Targeting early deaths following pancreaticoduodenectomy to improve survival","volume":"16","author":"Clark","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-023-05796-5_bb0130","doi-asserted-by":"crossref","unstructured":"Glebova NO, Hicks CW, Piazza KM, et al. Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection. Journal of Vascular Surgery. 2015. p. 424\u201333.","DOI":"10.1016\/j.jvs.2015.01.061"},{"issue":"5","key":"10.1007\/s11605-023-05796-5_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"23","key":"10.1007\/s11605-023-05796-5_bb0140","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1002\/cncr.28329","article-title":"Updated Long-Term Outcomes and Prognostic Factors for Patients With Unresectable Locally Advanced Pancreatic Cancer Treated With Intraoperative Radiotherapy at the Massachusetts General Hospital, 1978 to 2010","volume":"119","author":"Cai","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1007\/s11605-023-05796-5_bb0145","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1148\/rg.220020","article-title":"Portal Interventions in the Setting of Venous Thrombosis or Occlusion","volume":"42","author":"Salei","year":"2022","journal-title":"Radiographics"},{"issue":"1","key":"10.1007\/s11605-023-05796-5_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Ann Surg"},{"issue":"11","key":"10.1007\/s11605-023-05796-5_bb0155","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer","volume":"27","author":"Lacobuzio-Donahue","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1007\/s11605-023-05796-5_bb0160","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1245\/s10434-015-5034-x","article-title":"Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients","volume":"23","author":"Kluger","year":"2015","journal-title":"Annals of Surgical Oncology"},{"issue":"3","key":"10.1007\/s11605-023-05796-5_bb0165","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (Stage III) pancreatic adenocarcinoma patients with irreversible electroporation safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-023-05796-5_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2015.10.019","article-title":"Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis","volume":"111","author":"Bell","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1007\/s11605-023-05796-5_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejim.2015.10.001","article-title":"Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies","volume":"28","author":"Gariani","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1007\/s11605-023-05796-5_bb0180","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1111\/jth.15818","article-title":"Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population","volume":"20","author":"Raskob","year":"2022","journal-title":"Journal of Thrombosis and Haemostasis"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-023-05796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-023-05796-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-023-05796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:08:07Z","timestamp":1761077287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1091255X24000520"],"URL":"https:\/\/doi.org\/10.1007\/s11605-023-05796-5","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-023-05796-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}